Items where Author is "Heininger, U."
Number of items: 115. 2023Kohns Vasconcelos, M. and Meyer Sauteur, P. M. and Keitel, K. and Santoro, R. and Egli, A. and Coslovsky, M. and Seiler, M. and Lura, M. and Köhler, H. and Loevy, N. and Kahlert, C. R. and Heininger, U. and Van den Anker, J. and Bielicki, J. A.. (2023) Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland - baseline findings from the first two years of the KIDS-STEP trial. Swiss Med Wkly, 153. p. 40040. 2022Jaeger, F. N. and Berger, C. and Buettcher, M. and Depallens, S. and Heininger, U. and Heller, Y. and Kohns Vasconcelos, M. and Leforestier, B. and Pellaud, N. and Relly, C. and Truck, J. and von Overbeck Ottino, S. and Wagner, N. and Ritz, N. and Migrant Health Reference Group of Paediatrics Switzerland, and Paediatric Infectious Disease Group in Switzerland, . (2022) Paediatric refugees from Ukraine: guidance for health care providers. Swiss Med Wkly, 152 (21-22). w30200. 2021Roelens, M. and Martin, A. and Friker, B. and Sousa, F. M. and Thiabaud, A. and Vidondo, B. and Buchter, V. and Gardiol, C. and Vonlanthen, J. and Balmelli, C. and Battegay, M. and Berger, C. and Buettcher, M. and Cusini, A. and Flury, D. and Heininger, U. and Niederer-Loher, A. and Riedel, T. and Schreiber, P. W. and Sommerstein, R. and Troillet, N. and Tschudin-Sutter, S. and Vetter, P. and Bernhard-Stirnemann, S. and Corti, N. and Gaudenz, R. and Marschall, J. and Nussbaumer-Ochsner, Y. and Senn, L. and Vuichard-Gysin, D. and Zimmermann, P. and Zucol, F. and Iten, A. and Keiser, O.. (2021) Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Swiss Med Wkly, 151. w30105. Kohns Vasconcelos, M. and Meyer Sauteur, P. M. and Keitel, K. and Santoro, R. and Heininger, U. and van den Anker, J. and Bielicki, J. A.. (2021) Strikingly decreased community-acquired pneumonia admissions in children despite open schools and day-care facilities in Switzerland. The Pediatric infectious disease journal, 40 (4). e171-e172. 2020Kohns Vasconcelos, M. and Meyer Sauteur, P. M. and Santoro, R. and Coslovsky, M. and Lura, M. and Keitel, K. and Wachinger, T. and Beglinger, S. and Heininger, U. and van den Anker, J. and Bielicki, J. A.. (2020) Randomised placebo-controlled multicentre effectiveness trial of adjunct betamethasone therapy in hospitalised children with community-acquired pneumonia: a trial protocol for the KIDS-STEP trial. BMJ Open, 10 (12). e041937. 2015Marschall, K. and Hoernes, M. and Bitzenhofer-Gruber, M. and Jandus, P. and Duppenthaler, A. and Wuillemin, W. A. and Rischewski, J. and Boyman, O. and Heininger, U. and Hauser, T. and Steiner, U. and Posfay-Barbe, K. and Seebach, J. and Recher, M. and Hess, C. and Helbling, A. and Reichenbach, J. and Swiss, P. I. D. Registry Working Group. (2015) The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014. Clinical & Experimental Immunology, 182 (1). pp. 45-50. 2014Beckmann, C. and Heininger, U. and Marti, H. and Hirsch, H. H.. (2014) Gastrointestinal pathogens detected by multiplex nucleic acid amplification testing in stools of pediatric patients and patients returning from the tropics. Infection, 42 (6). pp. 961-970. 2013Baer, G. and Baumann, P. and Buettcher, M. and Heininger, U. and Berthet, G. and Schafer, J. and Bucher, H. C. and Trachsel, D. and Schneider, J. and Gambon, M. and Reppucci, D. and Bonhoeffer, J. M. and Stahelin-Massik, J. and Schuetz, P. and Mueller, B. and Szinnai, G. and Schaad, U. B. and Bonhoeffer, J.. (2013) Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS ONE, 8 (8). e68419. 2012Sidler, J. A. and Haberthur, C. and Dumoulin, A. and Hirsch, H. H. and Heininger, U.. (2012) A retrospective analysis of nosocomial viral gastrointestinal and respiratory tract infections. Pediatric infectious disease journal, Vol. 31, no. 12. pp. 1233-1238. 2011Höhle, M. and Siedler, A. and Bader, H.-M. and Ludwig, M. and Heininger, U. and V. O. N. Kries, R.. (2011) Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiology and Infection, 139 (11). pp. 1710-1719. Heininger, U.. (2011) Pneumococcal conjugate vaccines = Pneumokokken-Konjugatvakzinen : epidemiology guides clinical use : Epidemiologie leitet den klinischen Einsatz. Klinische Pädiatrie, Vol. 223, H. 2. pp. 59-60. Cherry, J. D. and Paddock, C. D. and Greer, P. W. and Heininger, U.. (2011) The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initially PCR-positive or PCR-negative for Bordetella pertussis. Infection, 39 (6). pp. 545-548. 2010Spackova, M. and Wiese-Posselt, M. and Dehnert, M. and Matysiak-Klose, D. and Heininger, U. and Siedler, A.. (2010) Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine, Vol. 28, no. 3. pp. 686-691. Bonhoeffer, J. and Trachsel, D. and Hammer, J. and Nava, E. and Heininger, U.. (2010) Lemierre syndrome and nosocomial transmission of Fusobacterium necrophorum from patient to physician. Klinische Pädiatrie, 222 (7). pp. 464-466. Mégevand, C. and Gervaix, A. and Heininger, U. and Berger, C. and Aebi, C. and Vaudaux, B. and Kind, C. and Gnehm, H.-P. and Hitzler, M. and Renzi, G. and Schrenzel, J. and Fran?ois, P.. (2010) Molecular epidemiology of the nasal colonization by methicillin-susceptible staphylococcus aureus in Swiss children. Clinical microbiology and infection, Vol. 16, no. 9. pp. 1414-1420. Schumacher, Z. and Bourquin, C. and Heininger, U.. (2010) Surveillance for adverse events following immunization (AEFI) in Switzerland - 1991-2001. Vaccine, Vol. 28, no. 24. pp. 4059-4064. 2008Heininger, U.. (2008) Akute Otitis media - Einfluss der Pneumokokkenimpfung auf die Prävalenz. Monatsschrift Kinderheilkunde, 156 (6). pp. 545-549. Meury, S. N. and Erb, T. and Schaad, U. B. and Heininger, U.. (2008) Randomized, comparative efficacy trial of oral penicillin versus cefuroxime for perianal streptococcal dermatitis in children. Journal of Pediatrics, 153 (6). pp. 799-802. Reinhardt, D. and Heininger, U.. (2008) Stellungnahme zu medizinischen Massnahmen bei immigrierenden Kindern und Jugendlichen. Monatsschrift Kinderheilkunde, Bd. 156, H. 2. pp. 170-175. Crameri, S. and Heininger, U.. (2008) Successful control of a pertussis outbreak in a university children's hospital. International journal of infectious diseases, Vol. 12, no. 6 , e85-87. 2007Heininger, U. and Sänger, R. and Jacquet, J.-M. and Schuerman, L.. (2007) Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life : safety, immunogenicity and persistence of antibody responses. Vaccine, Vol. 25, no. 6. pp. 1055-1063. Hammerschmidt, T. and Forster, J. and Huppertz, I. and Heininger, U. and Roos, R. and Standaert, B. A.. (2007) Epidemiologic and economic impact of routine vaccination of infants against rotavirus gastroenteritis in Germany : a preliminary analysis. Value in health, Vol. 10, no. 6 , A437. Heininger, U.. (2007) Influenza im Kindesalter - ein epidemiologisches Problem. Therapeutische Umschau, Bd. 64, H. 11. pp. 643-647. 2006Tapiainen, T. and Bar, G. and Bonhoeffer, J. and Heininger, U.. (2006) Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine, Vol. 24, H. 9. pp. 1483-1487. Heininger, U. and Buettcher, M. and Baer, G. and Bonhoeffer, J. and Schaad, U. B.. (2006) Prospective surveillance of hospitalisation due to intussusception and association with rotavirus infection in children. Swiss Medical Weekly, Vol. 136, Suppl. 151 , S. 44S. 2005Tillmann, B. U. and Tillmann, H. C. and Heininger, U. and Lutschg, J. and Weber, P.. (2005) Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. European journal of pediatrics, Vol. 164, H. 5. pp. 320-325. Schulzke, S. and Heininger, U. and Lucking-Famira, M. and Fahnenstich, H.. (2005) Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. European journal of pediatrics, Vol. 164, H. 7. pp. 432-435. Heininger, U.. (2005) Diagnosing tuberculosis. Archives of Disease in Childhood, 90 (11). p. 1104. Tapiainen, T. and Cherry, J. D. and Heininger, U.. (2005) Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants. Vaccine, Vol. 23, no. 43. pp. 5106-5112. Posfay-Barbe, K. M. and Heininger, U. and Aebi, C. and Desgrandchamps, D. and Vaudaux, B. and Siegrist, C. A.. (2005) How do physicians immunize their own children? : Differences among pediatricians and nonpediatricians. Pediatrics, Vol. 116, H. 5 , E623-E633. Bonhoeffer, J. and Baer, G. and Muehleisen, B. and Aebi, C. and Nadal, D. and Schaad, U. B. and Heininger, U.. (2005) Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. European journal of pediatrics, Vol. 164, H. 6. pp. 366-370. Landolt, M. and Heininger, U.. (2005) Prävalenz der streptogenen perianalen Dermatitis bei Kindern und Jugendlichen. Schweizerische Rundschau für Medizin Praxis, 94, Nr. 38. pp. 1467-1471. Heininger, U. and Bae, G. and Bonhoeffer, J. and Schaad, U. B.. (2005) Reliability of varicella history in children and adolescents. Swiss Medical Weekly, Vol. 135, H. 17-18. pp. 252-255. Bonhoeffer, J. and Zumbrunn, B. and Heininger, U.. (2005) Reporting of vaccine safety data in publications : systematic review. Pharmacoepidemiology and drug safety, Vol. 14, H. 2. pp. 101-106. Baer, G. and Bonhoeffer, J. and Schaad, U. B. and Heininger, U.. (2005) Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine, Vol. 23, no. 16. pp. 2016-2020. Bonhoeffer, J. and Bär, G. and Riffelmann, M. and Solèr, M. and Heininger, U.. (2005) The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection, 33 (1). pp. 13-17. 2004Meury, S. and Zeller, S. and Heininger, U.. (2004) Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. European journal of pediatrics, Vol. 163, H. 7. pp. 359-363. Heininger, U. and Frei, R. and Cherry, J. D. and Stehr, K.. (2004) Comparison of pulsed field gel electrophoresis patterns of Bordetella pertussis isolates from unvaccinated children with severe or mild pertussis. Pediatric infectious disease journal, Vol. 23, no. 3. pp. 211-217. Beckers, K. and Schaad, U. B. and Heininger, U.. (2004) Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns. European journal of pediatrics, Vol. 163, H. 11. pp. 654-657. Cherry, J. D. and Xing, D. X. L. and Newland, P. and Patel, K. and Heininger, U. and Corbel, M. J.. (2004) Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clinical infectious diseases, Vol. 38, no. 4. pp. 502-507. Agyeman, P. and Duppenthaler, A. and Heininger, U. and Aebi, C.. (2004) Influenza-associated myositis in children. Infection, 32 (4). pp. 199-203. Schulzke, S. and Adler, H. and Bar, G. L. and Heininger, U. and Hammer, J.. (2004) Mycobacterium bohemicum - a cause of paediatric cervical lymphadenitis. Swiss Medical Weekly, Vol. 134, H. 15-16. pp. 221-222. Heininger, U.. (2004) Risiken von Infektionskrankheiten und der Nutzen von Impfungen. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, Jg. 47, Nr. 12. pp. 1129-1135. Zepp, F. and Knuf, M. and Heininger, U. and Jahn, K. and Collard, A. and Habermehl, P. and Schuerman, L. and Sanger, R.. (2004) Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Vaccine, Vol. 22, no. 17-18. pp. 2226-2233. Bonhoeffer, J. and Heininger, U. and Kohl, K. and Chen, R. T. and Duclos, P. and Heijbel, H. and Jefferson, T. and Loupi, E.. (2004) Standardized case definitions of adverse events following immunization (AEFI). Vaccine, Vol. 22, no. 5/6. pp. 547-550. Bonhoeffer, J. and Kohl, K. and Chen, R. and Duclos, P. and Heijbel, H. and Heininger, U. and Jefferson, T. and Loupi, E.. (2004) The Brighton collaboration - enhancing vaccine safety. Vaccine, Vol. 22, no. 15-16. p. 2046. 2003Heininger, U. and Bachler, M. and Schaad, U. B.. (2003) Attitudes of pediatricians regarding influenza self-immunization : a survey in a Swiss university children`s hospital. Pediatric infectious disease journal, Vol. 22, no. 5. pp. 391-394. Szinnai, G. and Farron, F. and Bar, G. and Heininger, U.. (2003) Herpes zoster and aseptic meningitis in a previously healthy child. European Journal of Pediatrics, Vol. 162, H. 6. pp. 434-435. Ruof, H. R. and Rudin, C. and Heininger, U.. (2003) Influenza-like symptoms and thrombocytopenia in a teenager. Pediatric infectious disease journal, Vol. 22, no. 1. p. 89. Baer, G. and Bonhoeffer, J. and Schaad, U. B. and Heininger, U.. (2003) Protection against vaccine-preventable diseases in medical students. Pediatric infectious disease journal, Vol. 22, no. 4. pp. 373-374. Heininger, U.. (2003) Prävention von Pneumokokkeninfektionen. Monatsschrift Kinderheilkunde, Bd. 151, H. 4. pp. 391-396. Baer, G. and Engelcke, G. and Abele-Horn, M. and Schaad, U. B. and Heininger, U.. (2003) Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. European journal of clinical microbiology & infectious diseases, Vol. 22, H. 12. pp. 742-745. Kohl, K. S. and Bonhoeffer, J. and Chen, R. and Duclos, P. and Heijbel, H. and Heininger, U. and Loupi, E.. (2003) The Brighton Collaboration : enhancing comparibility of vaccine safety data. Pharmacoepidemiology and drug safety, Vol. 12, H. 4. pp. 335-340. 2002Gissler, S. and Heininger, U.. (2002) Borrelia lymphocytoma ("lymphadenosis benigna cutis"). Archives of disease in childhood, Vol. 87, no. 1. p. 12. Heininger, U.. (2002) Introduction of pneumococcal vaccine to standard immunisation programmes in Europe : what are we waiting for? European Journal of Pediatrics, Vol. 161, Suppl. 2 , S. S125-S126. Heininger, U.. (2002) Letter to the editor. Vaccine, Vol. 20, no. 11/12. p. 1480. Bonhoeffer, J. and Kohl, K. and Chen, R. and Duclos, P. and Heijbel, H. and Heininger, U. and Jefferson, T. and Loupi, E.. (2002) The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine, Vol. 21, no. 3-4. pp. 298-302. Scholz, Horst and Vogel, Friedrich and Abele-Horn, M. and Adam, D. and Belohradsky, B. H. and Handrick, W. and Heininger, U. and Luckhaupt, H. and Noack, R. and Roos, R. and Paul Ehrlich Society for Chemotherapy, . (2002) [Rational use of oral antibiotics in children and young people : Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy ]. Medizinische Monatsschrift für Pharmazeuten, Vol. 25, H. 6. pp. 205-216. 2001Bonhoeffer, J. and Haeberle, B. and Schaad, U. B. and Heininger, U.. (2001) Diagnosis of acute haematogenous osteomyelitis and septic arthritis : 20 years experience at the University Children's Hospital Basel. Swiss Medical Weekly, Vol. 131, H. 39/40. pp. 575-581. Siegrist, C. and Desgrandchamps, D. and Heininger, U. and Vaudaux, B.. (2001) How to improve communication on vaccine issues at the national level? : INFOVAC-PED : an example from Switzerland. Vaccine, Vol. 20, Suppl. 1 , S. S98-S100. Bartels, I. and Jüngert, J. and Lugauer, S. and Stehr, K. and Heininger, U.. (2001) Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults. Vaccine, Vol. 19, no. 23-24. pp. 3137-3145. Frühwirth, M. and Heininger, U. and Ehlken, B. and Petersen, G. and Laubereau, B. and Moll-Schüler, I. and Mutz, I. and Forster, J.. (2001) International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatric infectious disease journal, Vol. 20, no. 8. pp. 784-791. Szinnai, G. and Schaad, U. B. and Heininger, U.. (2001) Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature. European journal of pediatrics, Vol. 160, H. 9. pp. 528-533. Heininger, U.. (2001) Needle length and incidence of local reactions to immunisation : Is there a real benefit for the child? BMJ, vol. 322, no. 7284. pp. 492-493. Jüngert, J. M. and Uberall, M. and Mayer, U. M. and Guggenbichler, J. P. and Heininger, U.. (2001) Papillenödem und akute bilaterale Amaurose bei akuter Sinusitis. Klinische Pädiatrie, Vol. 213, H. 6. pp. 343-346. Heininger, U.. (2001) Pertussis : an old disease that is still with us. Current opinion in infectious diseases, Vol. 14, no. 3. pp. 329-335. Lugauer, S. and Stehr, K. and Wirsing von König, C. H. and Heininger, U.. (2001) Pertussis im Erwachsenenalter : Krankheitsbild, Epidemiologie und Prophylaxe. Deutsche medizinische Wochenschrift, Jg. 126, H. 45. pp. 1272-1277. Heininger, U.. (2001) Recent progress in clinical and basic pertussis research. European journal of pediatrics, Vol. 160, H. 4. pp. 203-213. Heininger, U. and Braun-Fahrländer, C. and Desgrandchamps, D. and Glaus, J. and Grize, L. and Wutzler, P. and Schaad, U. B. and Scarpol Team, . (2001) Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatric infectious disease journal, Vol. 20, no. 8. pp. 775-778. Heininger, U.. (2001) Uncomplicated acute bronchitis. Annals of internal medicine, Vol. 135, H. 9. pp. 839-840. Heininger, U.. (2001) World wide wasting? Archives of disease in childhood, Vol. 85, no. 1. p. 46. 2000Brazzola, P. and Zbinden, R. and Rudin, C. and Schaad, U. B. and Heininger, U.. (2000) Brevibacterium casei sepsis in an 18-year-old female with AIDS. Journal of clinical microbiology, Vol. 38, H. 9. pp. 3513-3514. Heininger, U. and Schmidt-Schläpfer, G. and Cherry, J. D. and Stehr, K.. (2000) Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics, Vol. 105, H. 3 , E31. Klinge, J. and Lugauer, S. and Korn, K. and Heininger, U. and Stehr, K.. (2000) Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age. Vaccine, Vol. 18, no. 27. pp. 3134-3140. Laubereau, B. and Zwahlen, M. and Neuenschwander, B. and Heininger, U. and Schaad, U. B. and Desgrandchamps, D.. (2000) Herpes-simplex-Virus Typ 1 und 2 in der Schweiz. Schweizerische medizinische Wochenschrift, Jg. 130, H. 5. pp. 143-150. von der Hardt, K. and Jüngert, J. and Beck, J. D. and Heininger, U.. (2000) Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents - a retrospective analysis. Vaccine, Vol. 18, no. 26. pp. 2999-3004. Girisch, M. and Heininger, U.. (2000) Scarlet fever associated with hepatitis : a report of two cases. Infection, 28 (4). pp. 251-253. Desgrandchamps, D. and Schaad, U. B. and Glaus, J. and Tusch, G. and Heininger, U.. (2000) Seroprävalenz von IgG-Antikörpern gegen Masern, Mumps und Röteln bei Schweizer Kindern in den ersten 16 Lebensmonaten. Schweizerische medizinische Wochenschrift, Jg. 130, Nr. 41. pp. 1479-1486. 1999Heininger, U. and Stehr, K. and Christenson, P. and Cherry, J. D.. (1999) Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clinical infectious diseases, Vol. 28, no. 3. pp. 602-604. Girisch, M. and Fartasch, M. and Schroth, M. and Rauch, R. and Leipold, G. and Franz, K. and Heininger, U.. (1999) Kongenitale Langerhans-Zellen-Histiozytose unter dem klinischen Bild einer Varizelleninfektion. Klinische Pädiatrie, Vol. 211, H. 5. pp. 403-405. Bartel, K. and Habash, T. and Lugauer, S. and Bärmeier, H. and Böwing, B. and Unsal, M. and Schoerner, C. and Heininger, U.. (1999) Optimal tobramycin dosage in patients with cystic fibrosis : evidence for predictability based on previous drug monitoring. Infection, 27 (4-5). pp. 268-271. Laubereau, B. and Gateau, S. and Ehlken, B. and Huber, K. and Rohwedder, A. and Gervaix, A. and Heininger, U. and Schaad, U. B.. (1999) Rotavirus-Gastroenteritis im Säuglings- und Kleinkindesalter : Ergebnisse einer prospektiven Erfassung in den Regionen Genf und Basel 1997/1998 (RoMoS). Schweizerische medizinische Wochenschrift, Jg. 129, Nr. 47. pp. 1822-1830. Heininger, U.. (1999) [Special aspects of borreliosis in childhood]. Schweizerische Rundschau für Medizin Praxis, 88, Nr. 45. pp. 1877-1879. 1998Stehr, K. and Cherry, J. D. and Heininger, U. and Schmitt-Grohé, S. and uberall, M. and Laussucq, S. and Eckhardt, T. and Meyer, M. and Engelhardt, R. and Christenson, P.. (1998) A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics, Vol. 101, H.1. pp. 1-11. Cherry, J. D. and Gornbein, J. and Heininger, U. and Stehr, K.. (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine, Vol. 16, no. 20. pp. 1901-1906. Heininger, U. and Cherry, J. D. and Stehr, K. and Schmitt-Grohé, S. and Uberall, M. and Laussucq, S. and Eckhardt, T. and Meyer, M. and Gornbein, J.. (1998) Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure : pertussis vaccine study group. Pediatrics, Vol. 102, H. 3. pp. 546-553. Müller, F. M. and Heininger, U. and Schnitzler, N. and Kockelkorn, P. and Cloot, O. and Lorenz, C. and Haase, G.. (1998) Discrimination of Bordetella parapertussis and Bordetella pertussis organisms from clinical isolates by PCR using biotin-labelled oligonucleotide probes. Molecular and cellular probes, Vol. 12, H. 4. pp. 213-217. Yuk, M. H. and Heininger, U. and Martínez de Tejada, G. and Miller, J. F.. (1998) Human but not ovine isolates of Bordetella parapertussis are highly clonal as determined by PCR-based RAPD fingerprinting. Infection, 26 (5). pp. 270-273. Martinez de Tejada, G. and Cotter, P. A. and Heininger, U. and Camilli, A. and Akerley, B. J. and Mekalanos, J. J. and Miller, J. F.. (1998) Neither the Bvg- phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. Infection and immunity, Vol. 66, H. 6. pp. 2762-2768. Cherry, J. D. and Heininger, U. and Stehr, K. and Christenson, P.. (1998) The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics, Vol. 102, H. 4. pp. 909-912. Heininger, U. and Stehr, K. and Cherry, J. D.. (1998) The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model. Vaccine, Vol. 16, no. 13. p. 1255. 1997Heininger, U. and Klich, K. and Stehr, K. and Cherry, J. D.. (1997) Clinical findings in Bordetella pertussis infections : results of a prospective multicenter surveillance study. Pediatrics, Vol. 100, H. 6 , E10. Schmitt-Grohé, S. and Stehr, K. and Cherry, J. D. and Heininger, U. and Uberall, M. A. and Laussucq, S. and Eckhardt, T.. (1997) Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine : the pertussis vaccine study Group. Developments in biological standardization, vol. 89. pp. 113-118. Uberall, M. A. and Stehr, K. and Cherry, J. D. and Heininger, U. and Schmitt-Grohé, S. and Laussucq, S. and Eckhardt, T.. (1997) Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine : the pertussis vaccine study group. Developments in biological standardization, vol. 89. pp. 83-89. 1996Hausman, S. Z. and Cherry, J. D. and Heininger, U. and Wirsing von König, C. H. and Burns, D. L.. (1996) Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infection and immunity, Vol. 64, H. 10. pp. 4020-4026. Heininger, U. and Stehr, K. and Schmidt-Schläpfer, G. and Penning, R. and Vock, R. and Kleemann, W. and Cherry, J. D.. (1996) Bordetella pertussis infections and sudden unexpected deaths in children. European Journal of pediatrics, Vol. 155, H. 7. pp. 551-553. 1995Heininger, U. and Stehr, K. and Schmitt-Grohe, S. and Uberall, M. and Lorenz, C. and Rost, R. and Cherry, J. D.. (1995) Der Mikroagglutinationstest : ein einfaches und sensitives Verfahren zur Serodiagnostik von Pertussisinfektionen. Klinische Pädiatrie, Vol. 207, H. 5. pp. 277-280. Stehr, K. and Heininger, U. and Uhlenbusch, R. and Angersbach, P. and Hackell, J. and Eckhardt, T.. (1995) Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children : monovalent acellular pertussis vaccine study group. European Journal of pediatrics, Vol. 154, H. 3. pp. 209-214. Schmitt-Grohé, S. and Cherry, J. D. and Heininger, U. and Uberall, M. A. and Pineda, E. and Stehr, K.. (1995) Pertussis in German adults. Clinical infectious diseases, Vol. 21, no. 4. pp. 860-866. Schläpfer, G. and Cherry, J. D. and Heininger, U. and Uberall, M. and Schmitt-Grohé, S. and Laussucq, S. and Just, M. and Stehr, K.. (1995) Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatric infectious disease journal, Vol. 14, no.3. pp. 209-214. Cherry, J. D. and Heininger, U. and Christenson, P. D. and Eckhardt, T. and Laussucq, S. and Hackell, J. G. and Mezzatesta, J. R. and Stehr, K.. (1995) Surrogate serologic tests for the prediction of pertussis vaccine efficacy. Annals of the New York Academy of Sciences, Vol. 754. pp. 359-363. 1994Heininger, U. and Stehr, K. and Schmitt-Grohé, S. and Lorenz, C. and Rost, R. and Christenson, P. D. and Uberall, M. and Cherry, J. D.. (1994) Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatric infectious disease journal, Vol. 13, no. 4. pp. 306-309. Heininger, U. and Cherry, J. D. and Christenson, P. D. and Eckhardt, T. and Göering, U. and Jakob, P. and Kasper, W. and Schweingel, D. and Laussucq, S. and Hackell, J. G.. (1994) Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine, Vol. 12, no. 1. pp. 81-86. Wolf, S. R. and Heininger, U. and Schneider, W. and Wenzel, D.. (1994) [Current aspects in diagnosis and therapy of pediatric facial paralysis]. HNO, Vol. 42, H. 10. pp. 624-628. 1993Heininger, U. and Böwing, B. and Stehr, K. and Solbach, W.. (1993) Aminoglykoside bei Patienten mit Mukoviszidose und pulmonaler Exazerbation : Vergleich von Einmal- und Dreimalgabe. Klinische Pädiatrie, Vol. 205, H. 1. pp. 18-22. Ries, M. and Deeg, K. H. and Heininger, U. and Stehr, K.. (1993) Brain abscesses in neonates : report of three cases. European Journal of Pediatrics, Vol. 152, H. 9. pp. 745-746. Heininger, U. and Cherry, J. D. and Eckhardt, T. and Lorenz, C. and Christenson, P. and Stehr, K.. (1993) Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatric infectious disease journal, Vol. 12, no. 6. pp. 504-509. Heininger, U. and Zimmermann, T. and Schoerner, C. and Brade, V. and Stehr, K.. (1993) [Tick bite and Lyme borreliosis : an epidemiologic study in the Erlangen area]. Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde, Vol. 141, H. 11. pp. 874-877. 1992Heininger, U. and Stehr, K. and Cherry, J. D.. (1992) Serious pertussis overlooked in infants. European Journal of Pediatrics, Vol. 151, H. 5. pp. 342-343. Heininger, U. and Storr, U. and Uberall, M. A. and Guggenbichler, J. P. and Stehr, K.. (1992) [Pertussis--an illness with typical clinical symptoms?]. Monatsschrift Kinderheilkunde, Bd. 140, H. 10. pp. 753-755. 1991Heininger, U. and Ries, M. and Harms, D. and Brade, V.. (1991) Facial palsy with elevated protein in otherwise normal CSF in a child with Lyme disease. Infection, 19 (4). pp. 245-246. Heininger, U. and Böwing, B. and Forster, D. and Berthold, M.. (1991) Tumor-Nekrose-Faktor im Serum = Tumor necrosis factor in the serum : eine sinnvolle Ergänzung der Entzündungsdiagnostik bei Cystischer Fibrose? : a useful supplemental parameter in the diagnosis of infection in cystic fibrosis? Klinische Pädiatrie, Vol. 203, H. 3. pp. 158-161. 1990Ries, M. and Deeg, K. H. and Heininger, U.. (1990) Demonstration of perivascular echogenicities in congenital cytomegalovirus infection by colour Doppler imaging. European Journal of Pediatrics, Vol. 150, H. 1. pp. 34-36. Heininger, U. and Ries, M. and Christ, P. and Harms, D.. (1990) Simultaneous palsy of facial and vestibular nerve in a child with Lyme borreliosis. European Journal of Pediatrics, Vol. 149, H. 11. pp. 781-782. 1989Ries, M. and Heininger, U. and Deeg, K. H.. (1989) [An unusual late manifestation of hemorrhage caused by vitamin K deficiency]. Monatsschrift Kinderheilkunde, Bd. 137, H. 11. pp. 741-742. |
